Myriad Genetics Inc. (MYGN)

11.40
0.07 0.61
NASDAQ : Health Technology
Prev Close 11.47
Open 11.67
Day Low/High 11.40 / 12.02
52 Wk Low/High 9.24 / 48.40
Volume 876.84K
Avg Volume 1.21M
Exchange NASDAQ
Shares Outstanding 74.55M
Market Cap 861.85M
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Finding the stocks that have changed direction.

Rev's Forum: News Flow Works Against the Bears Once More

Rev's Forum: News Flow Works Against the Bears Once More

Those who thought we were ready to break down look foolish again.

Myriad Genetics Has Downside in Its DNA

Myriad Genetics Has Downside in Its DNA

All the long-term indicators are aligned for declines.

Why I Feel Bearish About the Market

Why I Feel Bearish About the Market

I'm not inclined to make market calls, but the action on my screen is pushing me to a defensive stance.

Myriad downgraded at Barclays

Myriad downgraded at Piper

Bull Chart of the Day: Myriad Genetics

Bull Chart of the Day: Myriad Genetics

The stock still maintains a bullish slant on the daily chart.

Myriad upgraded at Wells

Myriad downgraded at Credit Suisse

Myriad upgraded at JMP

Three Speculative Biotech Plays

Three Speculative Biotech Plays

Charting setups in Myriad Genetics, Clovis Oncology and Aegerion Pharma.

Myriad Genetics upgraded at JMP

Myriad Genetics downgraded at JMP

Myriad Genetics downgraded at JMP

Court Ruling Boosts Bio-Reference

Court Ruling Boosts Bio-Reference

Bio-Reference Labs CEO Dr. Marc Grodman says the Supreme Court ruling against human gene patents means big things for the testing industry.

Myriad downgraded at Jefferies

Earnings Roundup

Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...

Myriad Genetics downgraded at JP Morgan

Tough Trading in a Wobbly Market

At least the uptrend is still intact.

Myriad Genetics upgraded at BofA/Merrill